Consensus hVIVO plc

Equities

VENN

GB00B9275X97

Market Closed - London S.E. Other stock markets 11:35:00 2024-05-09 am EDT			5-day change	1st Jan Change
28 ^GBX	0.00%		+0.18%	+17.89%

Apr. 09	Transcript : HVIVO plc, 2023 Earnings Call, Apr 09, 2024
Apr. 09	HVIVO plc Provides Revenue Guidance for the Year 2024	CI

Evolution of the average Target Price on hVIVO plc

Price target over the last 5 years

History of analyst recommendation changes

b1fb5c06fd7bd3a.rlu19xqa7c80sjfJiQBpY_svKR6v7K6rNObN6yJRlG4.3AiHtV_Npq563GiO_y1bErxXbGnMis3BUp67rRs5zSvmM9i6LO-ovlPrYg~d3080eaffc332f8f83d477ef03aca6fe

Analyst Recommendations on hVIVO plc

HVIVO involvement in drug approval should boost interest	23-06-02	AN
Liberum Begins Open Orphan Coverage With Buy Rating	22-08-25	MT
FTSE 100 Closes Lower Awaiting Interest Rate News	22-06-14	DJ
FTSE Edges Lower as Fed Signals Earlier Rate Rise; Whitbread Gains	21-06-17	DJ
FTSE Seen Opening Lower After Fed Signaled Earlier Rate Rise	21-06-17	DJ

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.28 GBP

Average target price

0.3607 GBP

Spread / Average Target

+28.82%

High Price Target

0.41 GBP

Spread / Highest target

+46.43%

Low Price Target

0.29 GBP

Spread / Lowest Target

+3.57%

Consensus detail

Consensus revision (last 18 months)

Analysts covering hVIVO plc

Liberum Capital

Ratings for hVIVO plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar